Oncoloxía médica
Servicio
University Hospital of Zurich
Zúrich, SuizaPublicacións en colaboración con investigadores/as de University Hospital of Zurich (5)
2023
2022
-
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial
Annals of Oncology, Vol. 33, Núm. 2, pp. 181-192
2020
-
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Annals of Oncology, Vol. 31, Núm. 12, pp. 1734-1745
-
The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-19